Navigation Links
Jazz Pharmaceuticals Announces Third Quarter 2013 Financial Results
Date:11/5/2013

share-based compensation expense of $1,788 and $999, restructuring charges of $68 and $91, and transaction and integration costs of $33 and $0 for the nine months ended September 30, 2013 and 2012, respectively. (j)

Share-based compensation expense of $25,898 and $11,967, change in fair value of contingent consideration of $12,900 and $1,100, depreciation expense of $2,008 and $0, transaction and integration costs of $1,758 and $17,692, and restructuring charges of $1,389 and $2,089 for the nine months ended September 30, 2013 and 2012, respectively. (k)

Upfront license fees of $4,988 and $0, share-based compensation expense of $4,453 and $1,718, depreciation expense of $57 and $0, and transaction and integration costs of $55 and $0 for the nine months ended September 30, 2013 and 2012, respectively. (l)

Non-cash interest expense associated with debt discount and debt issuance costs for the nine months ended September 30, 2013. Non-cash interest expense associated with debt discount and debt issuance costs and amortization of product rights liability for the nine months ended September 30, 2012.(m)

Sum of adjustments (i) through (l) plus the adjustments for intangible asset amortization and, as applicable, loss on extinguishment and modification of debt, for the respective nine month period.(n)

Adjustments to convert the income tax provision to the estimated amount of taxes payable in cash for the nine months ended September 30, 2013. Tax related to acquisition restructuring of $15,379 partially offset by an adjustment of $9,219 to convert the income tax provision to the estimated amount of taxes payable in cash for the nine months ended September 30, 2012.(o)

Net of adjustments (m) and (n) for the respective nine month period. JAZZ PHARMACEUTICALS PLCRECONCILIATION OF GAAP TO NON-GAAP ADJUSTED 2013 GUIDANCE(In millions, except per share amounts)(Unaudited)GAAP net income

$223 - $233Intangible asset
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig
2. Aquavit Pharmaceuticals Adds New Advanced Drug Delivery Technology to Product Portfolio
3. Jazz Pharmaceuticals to Present at the 2013 Credit Suisse Healthcare Conference on November 12
4. Immune Pharmaceuticals Appoints Liquidity Provider to Facilitate Trading on NASDAQ OMX Stockholm Exchange
5. Actinium Pharmaceuticals to Host Corporate Update and Virtual Roadshow Conference Call on November 11
6. Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
7. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7
8. Merrimack Pharmaceuticals Announces Results From A Phase 2 Study Of MM-121 (SAR256212) In Combination With Paclitaxel In Patients With Platinum-Resistant Or Refractory Advanced Ovarian Cancers
9. Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update
10. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
11. Cumberland Pharmaceuticals To Announce Third Quarter 2013 Financial Results On November 5, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... MENLO PARK, Calif. , March 2, ... (OTCQX: DMPI) (DelMar and the Company), a company ... in new orphan drug indications, today announced that ... U.S. Patent and Trademark Office (USPTO) for patent ... to improve the therapeutic benefit of suboptimally administered ...
(Date:3/2/2015)... Ohio , March 2, 2015  Sarnova, ... the launch of the new www.tri-anim.com ... full-service, specialty healthcare distributor of respiratory, anesthesia and ... country. The site has many ... overall experience, making online shopping and ordering easier ...
(Date:3/2/2015)... , March 2, 2015  Maquet Medical Systems ... it has signed an exclusive distribution agreement with ... flagship product, the Flight 60 mechanical ventilator. The ... providing dependable and affordable mobility. Starting in the ... be sold in the United States ...
Breaking Medicine Technology:DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 3
... Midwest college that is producing alumni with sizeable reputations in ... Lilly Endowment to launch a School of Pharmacy. ... Laureate in chemistry, the inventor of Teflon®, the discoverer of ... of the U.S. Food and Drug Administration among its graduates. ...
... 20, 2010 Varian Medical Systems (NYSE: VAR ... quarter of fiscal year 2011 following the close of regular ... be followed by a teleconference available to all interested parties ... to the conference call webcast will be available on the ...
Cached Medicine Technology:Manchester College Receives $35 Million Grant From Lilly Endowment for School of Pharmacy 2Manchester College Receives $35 Million Grant From Lilly Endowment for School of Pharmacy 3Varian Medical Systems Schedules First Quarter FY2011 News Release and Conference Call 2
(Date:3/2/2015)... York (PRWEB) March 02, 2015 Tyrone ... Idoll Magazine, a medium for the model agency industry, ... find, and buy Mango, Passion Fruit, Pink Grapefruit, Pomegranate, ... 3rd, 2015, after 1pm. , At a cost of ... recently came under fire by announcing the brands commitment ...
(Date:3/2/2015)... Robins & Morton Celebrates Women In Construction ... Construction Week (March 1-7, sponsored by the National Association ... History Month, Robins & Morton is recognizing several women ... the construction industry as a whole. From the craft ... roles in between, each woman has a story to ...
(Date:3/2/2015)... Va. (PRWEB) March 02, 2015 The ... nonprofit authority on the use of health IT to ... white paper, “ICD-10 Testing for Small Providers.” The white ... with a starting point for ICD-10 testing by focusing ... payers to ensure compliance with the October 1, 2015 ...
(Date:3/2/2015)... NEW YORK, NY (PRWEB) March 02, 2015 ... kicks off March 2–8 and will provide opportunities for people ... find new ways to help people with MS live their ... recognize progress made and to inspire others to join the ... , Multiple sclerosis, an unpredictable, often disabling disease of the ...
(Date:3/2/2015)... March 02, 2015 Four Seasons Resort Maui ... its 25th anniversary this year, having officially opened its doors ... luxury resort is honoring over 70 employees who started on ... from amongst the approximately 400 original employees. The celebration ... Oceanfront Lawn. , This Four Seasons flagship resort, ...
Breaking Medicine News(10 mins):Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Robins & Morton Recognizes Women In Construction 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2
... 20 EmPower Research, LLC, a pioneer in,the ... its,first-ever study on the Indian Contract Research Organization ... Contract Research Industry, (CRO-nicles),captures the industry,s current position, ... top line industry executives first hand. India ...
... SAN DIEGO, Oct. 19 Local youth teamed up ... the San Diego,County Alcohol Policy Panel,s annual Legislative Forum ... as distilled spirits and to,investigate the labeling practices of ... enforcement officers and teachers energy drinks, some,with alcohol some ...
... WASHINGTON, Oct. 19 Following is a statement,by ... Healthcare Products,Association (CHPA), regarding the recommendations issued today ... Advisory Committee and,Pediatric Advisory Committee. At a meeting ... over-the-counter cough and cold medicines in children., ...
... Tablets are specially formulated ... for children, ... the safety and efficacy of many name brand,over-the-counter children,s cough and cold ... of their children,s cold and flu,symptoms. Hyland,s, Inc. is pleased to ...
... to State Supreme Court, WILMINGTON, Del., Oct. 19 ... in the Spelter, W.Va., zinc,smelter class action lawsuit. The ... J. Mobley. "We are extremely disappointed by the ... it has been unfairly punished for doing,the right thing ...
... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced today that ... registration statement with the Securities,and Exchange Commission relating to ... stock. In connection with this offering,Arena plans to grant ... to,an additional 1,500,000 shares of common stock to cover ...
Cached Medicine News:Health News:EmPower Research Launches Indian CRO Industry Report 2Health News:Youth and Health Experts Call on the Governor to Take the Buzz Out of Energy Drinks 2Health News:Statement from the Consumer Healthcare Products Association on Today's Joint FDA Advisory Committee Recommendations Regarding Pediatric Over-the-Counter Cough and Cold Medicines 2Health News:Hyland's Homeopathic Medicine Offers Parents Safe, All-Natural Option to Alleviate the Symptoms of Colds 2Health News:DuPont Responds to Spelter, W.Va., Lawsuit Decision 2Health News:Arena Pharmaceuticals Announces Public Offering of Common Stock 2
Straight shafts with two point fixation. Tips separated by 3 mm, each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with dull finish....
The Elschnig teeth of this forceps are ideal for grasping sclera during suturing. Delicate tying platform handles the finest suture material. 0.12 mm, 1 x 2 teeth....
Micro pierse type tips with 2 mm angled Colibri style jaws. Flat open serrated handle, dull finish....
Narrow 12 mm jaws with fine teeth. Serrated handle with polished finish....
Medicine Products: